HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$1.36
Day range
$1.31 - $1.37
Year range
$0.80 - $45.50
Market cap
22.17M USD
Avg Volume
8.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.24M | 60.61% |
Net income | -39.46M | -216.73% |
Net profit margin | — | — |
Earnings per share | -7.60 | -171.43% |
EBITDA | -16.20M | -60.48% |
Effective tax rate | -8.66% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.75M | -56.47% |
Total assets | 93.52M | -18.30% |
Total liabilities | 129.24M | 53.25% |
Total equity | -35.71M | — |
Shares outstanding | 16.30M | — |
Price to book | -0.21 | — |
Return on assets | -39.91% | — |
Return on capital | -4,487.56% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -39.46M | -216.73% |
Cash from operations | -10.48M | -38.78% |
Cash from investing | 8.07M | -25.73% |
Cash from financing | 2.03M | — |
Net change in cash | -643.00K | -118.18% |
Free cash flow | 5.52M | 294.96% |
About
Founded
2012
Headquarters
Website
Employees
38
